· 10/23/1992
Barr Laboratories, Inc. v. Abbott Laboratories
Citations
- 978 F.2d 98
- 978 F.3d 98
- 24 Fed. R. Serv. 3d 117
- 1992 U.S. App. LEXIS 27245
- 1992 WL 301618
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- recognizing that “existence of legitimate business justifications for the [exclusive dealing] contracts also supports the legality of the global contracts”
- explaining that courts must ―evaluate the restrictiveness and the economic usefulness of the challenged practice in relation to the business factors extant in the market‖
- explaining that courts must “evaluate the restrictiveness and the economic usefulness of the challenged practice in relation to the business factors extant in the market”
- acknowledging that the first question is whether there is an agreement to exclusivity
- remarking “market share of 47-50% alone [is] not enough to establish dangerous probability of success”
- remarking on a previous decision and observing that “we condemned the district court’s practice of bifurcating trials as a general rule”
Source: CourtListener parenthetical corpus (CC0).
Judges: Hutchinson, Cowen, Weis
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.